Stockreport

Eledon Pharmaceuticals launches proposed public offering of common stock and pre-funded warrants [Seeking Alpha]

Eledon Pharmaceuticals, Inc.  (ELDN) 
PDF The company said it plans to use the proceeds to advance its clinical development programs and for general corporate purposes. ELDN after hours to $2.08. Source: Pr [Read more]